European Pharmaceutical Review

MARCH 25, 2025

Expanding treatment options for atherosclerosis with an Lp(a) inhibitor “The drug is an important addition that expands and complements our cardio-metabolic pipeline, remarked Dr Dean Li, President, Merck Research Laboratories.

Research Laboratories 52

Research Laboratories Vaccines 52

European Pharmaceutical Review

MARCH 12, 2025

Early clinical data have provided robust evidence for the potential of CN201 to target and deplete circulating and tissue B cells with the potential to treat a range of malignant and autoimmune diseases, Dr Dean Li, President, Merck Research Laboratories shared at the time of the acquisition announcement.

Research Laboratories 52

Research Laboratories Vaccines Drug Development 52

STAT

SEPTEMBER 3, 2024

Ebert, chair of Dana-Farber’s medical oncology department and a prize-winning researcher, will take over from Glimcher on Oct. In his current role Ebert oversees more than half of Dana-Farber’s 556 faculty members and more than 80 research laboratories. 1, the Boston institute said in a statement on Tuesday.

Research Laboratories 285

Research Laboratories Hospitals 285

STAT

AUGUST 15, 2023

The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing. ( See page 42.)

Research Laboratories 246

Research Laboratories Documentation 246

STAT

AUGUST 16, 2023

 The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing.

Research Laboratories 246

Research Laboratories Documentation Pharmaceutical Companies Pharmaceutical Companies 246

PharmaTech

MARCH 17, 2023

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Research Laboratories 52

Research Laboratories 52

Pharma Mirror

SEPTEMBER 2, 2021

In-vitro studies conducted at the British virology research laboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19.

Research Laboratories 98

Research Laboratories 98

pharmaphorum

JUNE 30, 2022

. “The biopharmaceutical industry has only just started to harness the tremendous opportunity presented by emerging technological developments in AI and ML,” said Fiona Marshall, head of discovery, preclinical and translational medicine at Merck Research Laboratories.

Research Laboratories 134

Research Laboratories Drug Development Compounding 134

Pharmaceutical Technology

OCTOBER 14, 2022

Merck Research Laboratories chief medical officer, global clinical development head and senior vice-president Dr Eliav Barr said: “This long-term collaboration combining Merck’s expertise in immuno-oncology with Moderna’s pioneering mRNA technology has yielded a novel tailored vaccine approach.

Vaccines 115

Vaccines Research Laboratories Immunity Immunization 115

European Pharmaceutical Review

APRIL 17, 2023

“I look forward to working with the Prometheus team to establish a new paradigm of precision treatment for immune diseases,” commented Dr Dean Y Li, President of Merck Research Laboratories.

Research Laboratories 105

Research Laboratories Immunity Immunization 105

Express Pharma

JANUARY 30, 2024

The facility will focus on developing next-generation molecules using generative AI platforms, particularly in the ophthalmic, ENT, Paediatrics and skincare segments ENTOD Pharmaceuticals has inaugurated its state-of-the-art Research & Development Centre in Navi Mumbai on Sunday, January 28th.

Research Laboratories 109

Research Laboratories 109

Pharmacy Is Right For Me

APRIL 3, 2023

Pharmacists can work in a variety of settings, including hospitals, community pharmacies, research laboratories, and government agencies. Flexibility in work hours and settings Pharmacy offers a great deal of flexibility in terms of work hours and settings.

Research Laboratories 130

Research Laboratories Community Pharmacies Hospitals 130

European Pharmaceutical Review

OCTOBER 19, 2022

This is our second acquisition in gene therapy, following the 2021 acquisition of Prevail Therapeutics,” added Dr Daniel Skovronsky, Lilly’s Chief Scientific and Medical Officer and President of Lilly Research Laboratories. “With Akouos, we are optimistic that we can make a difference for people with hearing loss.”

Research Laboratories 98

Research Laboratories 98

European Pharmaceutical Review

MAY 30, 2024

Advancing the acquisition “By combining our strengths, we aim to advance with rigor and speed the development of their promising pipeline of candidates targeting retinal diseases,” stated Dr Dean Li , President, Merck Research Laboratories. “As

Research Laboratories 96

Research Laboratories Diabetes 96

European Pharmaceutical Review

NOVEMBER 22, 2022

Li, President of Merck Research Laboratories. “We Lysine-specific demethylase 1 (LSD1). Evidence indicates that LSD1 (KDM1A) plays an important role in the maturation of blood cells in the bone marrow,” noted Dr Dean Y.

Research Laboratories 98

Research Laboratories 98

European Pharmaceutical Review

JULY 7, 2022

At the beginning of his career in 2004, Dr Hughes was responsible for early clinical research at Bristol Myers-Squibb Company and then at Schering-Plough Research Institute. Dr Hughes earned his MD and PhD at Yale School of Medicine.

Research Laboratories 98

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Express Pharma

APRIL 17, 2023

By applying a portfolio of powerful analytic tools to a comprehensive collection of IBD samples, Prometheus identified important disease insights that have now yielded a promising late-stage candidate,” said Dr Dean Y Li, President, Merck Research Laboratories.

Immunity 98

Immunity Immunization Research Laboratories Labelling 98

European Pharmaceutical Review

NOVEMBER 4, 2022

Co-principal investigator on the study, Dr Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University added: “It often takes tens of millions of dollars and many years to do a head-to-head comparison of drugs.”.

Dosage 105

Dosage Research Laboratories 105

Express Pharma

AUGUST 7, 2024

This approach developed in collaboration between an academic research laboratory and a pharmaceutical company is not just about lowering cholesterol—it’s about creating a new paradigm to design drugs that can prevent diseases by targeting proteins more cleverly.

Research Laboratories 105

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies 105

Pharma Mirror

SEPTEMBER 9, 2021

Multiple flow chemistry platforms have been installed into a research laboratory at the site to allow the investigation of a wide range of chemical processes, including photolysis, electrochemistry and hydrogenations, as well. Announcement of the investment follows the appointment of Professor Ian R.

Research Laboratories 52

Research Laboratories 52

pharmaphorum

APRIL 7, 2022

Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while COVID-19 claimed the lives of 10 million.

Research Laboratories 98

Research Laboratories 98

Express Pharma

JULY 27, 2023

Global recruitment in V940-001 has begun, and the first patients are now enrolling in Australia.

Research Laboratories 98

Research Laboratories 98

Express Pharma

AUGUST 29, 2023

The triad event is well-known to bring top international and home-grown machinery manufacturers, suppliers of analytical instruments and laboratory equipment, leading pharma companies, research laboratories, consultants, industry experts and key government officials under one roof to network and unlock business opportunities.

Research Laboratories 105

Research Laboratories Packaging 105

Pharmaceutical Business Review

JULY 23, 2024

The centre will also be a hub for innovation, dedicating over half of its space to advanced research laboratories. A subsidiary of Bayer, the company aims to enhance its chemoproteomics screening capacity and further its clinical and preclinical programmes with this new facility.

Research Laboratories 59

Research Laboratories 59

Pharmaceutical Business Review

JULY 15, 2024

Merck Research Laboratories president Dr Dean Li said: “The EyeBio acquisition further diversifies our late-stage pipeline with the addition of a promising candidate based on novel biology and genetics for the treatment of certain retinal diseases.

Research Laboratories 59

Research Laboratories Diabetes Labelling 59

Pharmaceutical Technology

JUNE 28, 2022

Merck Research Laboratories global clinical development head, senior vice-president and chief medical officer Dr Eliav Barr said: “Patients with germline BRCA-mutated, HER2-negative early breast cancer will often develop breast cancer at an earlier age than those without BRCA mutations, impacting people in their prime.

Research Laboratories 64

Research Laboratories Chemotherapy 64

pharmaphorum

MAY 6, 2021

The company noted that Merck gained more than 100 regulatory approvals during Perlmutter’s seven-year tenure as president of Merck Research Laboratories, before retiring last year.

Research Laboratories 64

Research Laboratories 64

European Pharmaceutical Review

AUGUST 12, 2024

The bispecific antibody has shown potential to generate “significant and sustained reductions in B-cell populations”. For example, the data indicates that CN201 is well tolerated and active in relapsed or refractory B-cell haematologic malignancies.

Research Laboratories 59

Research Laboratories Chemotherapy Drug Development 59

Pharmaceutical Business Review

SEPTEMBER 28, 2023

Merck Research Laboratories global clinical development senior vice-president Dr Joerg Koglin said: “Despite advances in the treatment of PAH over the last two decades, there is still a significant need to improve outcomes for patients.

Research Laboratories 52

Research Laboratories 52

Pharmaceutical Technology

JUNE 7, 2023

Merck Research Laboratories global clinical development vice-president Dr Elizabeth Rhee stated: “PREVYMIS has been an important addition to the care of high-risk adult CMV-seropositive patients who have received allogeneic stem cell transplants to help prevent CMV infection and disease.

Research Laboratories 52

Research Laboratories 52

Pharmaceutical Technology

JUNE 23, 2022

Merck Research Laboratories global clinical development senior vice-president, head and chief medical officer Dr Eliav Barr said: “Our goal with Vaxneuvance is to expand coverage of key invasive disease-causing serotypes and provide a strong immune response to serotypes that pose substantial risk to infants and children.

Vaccines 59

Vaccines Research Laboratories Immunity Immunization 59

Pharmaceutical Technology

APRIL 4, 2023

Results showed that patients treated with Padcev along with KEYTRUDA achieved a confirmed ORR of 68%. 12% experienced a complete response and 55% a partial response.

Research Laboratories 52

Research Laboratories Chemotherapy 52

Pharmaceutical Technology

AUGUST 17, 2022

The rights to the oRNA-LNP technology platform of Orna will be retained by the company, which will also progress various other fully owned programmes in oncology and genetic disease areas. In addition, Merck will make a $100m equity investment in Orna’s Series B funding round concluded recently.

Vaccines 59

Vaccines Research Laboratories Packaging 59

Pharmaceutical Technology

DECEMBER 23, 2022

Merck Research Laboratories president Dr Dean Li said: “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site. Merck will also make tiered royalty payments on net sales for any ADC product commercialised to Kelun-Biotech.

Research Laboratories 52

Research Laboratories 52

pharmaphorum

MARCH 2, 2021

Keytruda’s other indications remain unaffected, and Roy Baynes, head of global clinical development at Merck Research Laboratories emphasised that Keytruda remains “foundational” for treatment of certain patients with non-small cell lung cancer.

Research Laboratories 59

Research Laboratories Chemotherapy 59

Pharmaceutical Technology

MAY 12, 2023

They have also created tissue research images at the IPU and other ICR research laboratories. Researchers at the unit are integrating digital pathology, tissue hybridisation and AI technologies to gain better understanding of major aspects of cancer pathology.

Research Laboratories 52

Research Laboratories Hospitals 52

pharmaphorum

JULY 13, 2022

“Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones,” said Dean Li, president of Merck Research Laboratories. It is rumoured to be near to announcing a $40 billion takeover bid for the biotech.

Research Laboratories 52

Research Laboratories Compounding 52